ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,392Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 278

$770K Total Retail Price of All Prescriptions

Rank: 50 out of 278

428 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 5,809 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 865 352 S3 1 1
LEVOTHYROXINE SODIUM 487 283 2 2
OMEPRAZOLE 374 236 3 3
SIMVASTATIN 269 207 4 4
FUROSEMIDE 190 122 5 6
GABAPENTIN 181 123 6 12
ZOLPIDEM TARTRATE 179 101 7 26
METOPROLOL SUCCINATE 164 114 8 10
LISINOPRIL 153 86 9 5
NEXIUM 140 67 10 14
AMLODIPINE BESYLATE 129 70 11 7
METFORMIN HCL 120 72 12 8
GLIMEPIRIDE 118 76 13 28
CRESTOR 114 80 14 19
CITALOPRAM HBR 104 83 15 21
TRAZODONE HCL 97 44 16 47
TRAMADOL HCL 96 42 17 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 69 18 31
ROPINIROLE HCL 92 54 19 69
CYCLOBENZAPRINE HCL 91 12 R 20 78
POTASSIUM CHLORIDE 91 46 20 17
PROMETHAZINE HCL 88 24 R 22 106
AZITHROMYCIN 86 51 23 39
PAROXETINE HCL 84 60 24 57
CEFDINIR 84 52 24 138
PRAVASTATIN SODIUM 83 53 26 16
WARFARIN SODIUM 83 69 26 11
METHYLPREDNISOLONE 79 50 28 124
METOPROLOL TARTRATE 79 57 28 9
FLUOXETINE HCL 79 49 28 68
SERTRALINE HCL 79 50 28 25
AMOXICILLIN 76 59 32 100
CLOPIDOGREL 76 53 32 20
GLYBURIDE-METFORMIN HCL 76 69 R 32 159
FENOFIBRATE 73 24 35 64
CIPROFLOXACIN HCL 73 49 35 65
TAMSULOSIN HCL 72 57 37 32
TIZANIDINE HCL 69 27 38 143
LOSARTAN-HYDROCHLOROTHIAZIDE 67 56 39 54
LANTUS 65 37 40 56
ATORVASTATIN CALCIUM 62 35 41 13
SPIRIVA 61 48 42 49
OXYCODONE HCL-ACETAMINOPHEN 59 0 S2 43 83
PLAVIX 55 38 44 30
CLONIDINE HCL 55 36 44 50
LANTUS SOLOSTAR 53 34 46 98
METFORMIN HCL ER 52 33 47 76
RISPERIDONE 52 11 47 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.